Cargando…
Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial
Background: The use of corticosteroids may help control the cytokine storm occurring in acute respiratory failure due to the severe form of COVID-19. We evaluated the postacute effect of corticosteroids used during the acute phase, such as impairment in pulmonary function parameters, on day 120 (D12...
Ejemplares similares
-
Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study
por: Freire Santana, Monique, et al.
Publicado: (2020) -
COVID-19-Associated Pulmonary Aspergillosis in a Series of Complete Autopsies from the Brazilian Amazon
por: Farias, Maria Eduarda, et al.
Publicado: (2022) -
Confirmed Invasive Pulmonary Aspergillosis and COVID-19: the value of postmortem findings to support antemortem management
por: Santana, Monique Freire, et al.
Publicado: (2020) -
Prevalence and force of Plasmodium vivax blood-stage infection and associated clinical malaria burden in the Brazilian Amazon
por: Monteiro, Wuelton, et al.
Publicado: (2022) -
Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone
por: Mwangi, Victor Irungu, et al.
Publicado: (2023)